Abstract
Previously diagnosed remote cerebrovascular infarction presenting with diminished FDG uptake corresponding to the hypodense area on CT at left parietal and frontal lobes
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Abele JT, Fung CI. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values. Radiology. 2010;254:917–24.
Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun. 2007;28:373–81.
Bredella MA, Essary B, Torriani M, Ouellette HA, Palmer WE. Use of FDG-PET in differentiating benign from malignant compression fractures. Skeletal Radiol. 2008;37:405–13.
Courtois A, Nusgens BV, Hustinx R, Namur G, Gomez P, Somja J, et al. 18F-FDG uptake assessed by PET/CT in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture. J Nucl Med. 2013;54:1740–7.
Ferdinand B, Gupta P, Kramer EL. Spectrum of thymic uptake at 18F-FDG PET. Radiographics. 2004;24:611–6.
Harisankar CN. Focal fat sparing of the liver: a nonmalignant cause of focal FDG uptake on FDG PET/CT. Clin Nucl Med. 2014;39:359–61.
Hollinger EF, Alibazoglu H, Ali A, Green A, Lamonica G. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med. 1998;23:93–8.
Hoffmann M, Kletter K, Becherer A, Jäger U, Chott A, Raderer M. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology. 2003;64:336–40.
Hoffmann M, Kletter K, Diemling M, Becherer A, Pfeffel F, Petkov V, et al. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. Ann Oncol. 1999;10:1185–9.
Jeong SY, Lee SW, Lee HJ, Kang S, Seo JH, Chun KA, et al. Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study. Eur J Nucl Med Mol Imaging. 2010;37:2334–43.
Karapolat I, Oncel G, Kumanlıoğlu K. Clinically occult pituitary adenoma can appear as a hypermetabolic lesion on whole body FDG PET imaging in a patient with lymphoma. Mol Imaging Radionucl Ther. 2013;22:18–20.
Kazama T, Swanston N, Podoloff DA, Macapinlac HA. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging. 2005;32:1406–11.
Klein JS, Braff S. Imaging evaluation of the solitary pulmonary nodule. Clin Chest Med. 2008;29:15–38.
Kwek BH, Aquino SL, Fischman AJ. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest. 2004;125:2356–60.
Limet R, Sakalihassan N, Albert A. Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg. 1991;14:540–8.
Lin CY, Lin WY, Lin CC, Shih CM, Jeng LB, Kao CH. The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET. Clin Imaging. 2011;35:437–41.
Makis W, Ciarallo A, Hickeson M, Rush C, Derbekyan V, Novales-Diaz JA, et al. Spectrum of gastric malignancy on 18F-FDG PET/CT: a pictorial essay. Clin Imaging. 2012;36:432–46.
Matsuda M, Sakamoto H, Okamura T, Nakai Y, Ohashi Y, Kawabe J, et al. Positron emission tomographic imaging of pleomorphic adenoma in the parotid gland. Acta Otolaryngol Suppl. 1998;538:214–20.
Mehta A, Blodgett TM. Retroperitoneal fibrosis as a cause of positive FDG PET/CT. J Radiol Case Rep. 2011;5:35–41.
Mert M, Kocabay G, Ozülker T, Temizel M, Yanar H, Uygun O, et al. Liver abscess due to Yersinia bacteremia in a well-controlled type I diabetic patient. Endokrynol Pol. 2011;62:357–60.
Mostard RL, Prompers L, Weijers RE, van Kroonenburgh MJ, Wijnen PA, Geusens PP, et al. F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med. 2012;37:21–5. doi:10.1097/RLU.0b013e3182335f9b.
Ozülker T, Ozülker F, Mert M, Ozpaçaci T. Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug. Eur J Nucl Med Mol Imaging. 2010;37:1011–7. doi:10.1007/s00259-009-1330-7.
Özülker T, Özülker F, Özpaçacı T. Incidental finding of bladder diverticula on F-18 FDG PET/CT and whole body bone scintigraphy. Turk J Nucl Med. 2009;18:55–7.
Rudd JH, Myers KS, Bansilal S, Machac J, Pinto CA, Tong C, et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871–8. doi:10.2967/jnumed.107.050294.
Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365:1577–89.
Stubbs E, Kraas J, Morton KA, Clark PB. Brain abnormalities detected on whole-body 18F-FDG PET in cancer patients: spectrum of findings. AJR Am J Roentgenol. 2007;188:866–73.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Özülker, T., Özülker, F. (2015). Normal Variants and Benign Findings. In: Atlas of PET-CT Imaging in Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-18994-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-18994-9_2
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18993-2
Online ISBN: 978-3-319-18994-9
eBook Packages: MedicineMedicine (R0)